CARSON RUSSELL L 4
4 · SELECT MEDICAL HOLDINGS CORP · Filed Jul 1, 2026
Research Summary
AI-generated summary of this filing
Select Medical (SEM) Director Carson Russell Disposes 610,035 Shares in Merger
What Happened
- Carson Russell, a director of Select Medical Holdings Corp (SEM), recorded a disposition of 610,035 common shares on 2026-06-30 (transaction code J — other acquisition/disposition). The reported price per share was $0.00 because the shares were not sold for cash but were contributed and exchanged under the merger agreement. As described in the filing, the shares were contributed to Parent in exchange for Parent common shares, which were then exchanged for interests in Stallion Group Parent, LP. Of the contributed shares, 14,035 were restricted shares that vested immediately before the merger effective time.
Key Details
- Transaction date: 2026-06-30; Form 4 filed: 2026-07-01 (timely filing).
- Shares disposed: 610,035; reported price: $0.00 (non-cash exchange).
- Footnotes: Merger Agreement dated March 2, 2026; contribution to Parent, exchange for Parent common shares, then converted to interests in Stallion Group Parent, LP. 14,035 restricted shares vested immediately prior to the merger.
- Filing does not report a cash sale — this was a corporate merger exchange, not an open-market transaction.
Context
- This is a merger-related disposition (corporate transaction), not a routine market sale; such exchanges convert company stock into consideration specified by the merger agreement and do not necessarily signal the insider’s view of the company’s future. For retail investors, purchases generally carry more direct informational value than merger conversions like this.
Insider Transaction Report
Form 4Exit
CARSON RUSSELL L
Director
Transactions
- Other
Common Stock
[F1][F2]2026-06-30−610,035→ 0 total
Footnotes (2)
- [F1]This Form 4 reports securities disposed of under the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation ("Parent"), and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026).
- [F2]Immediately prior to the effective time of the merger, the Reporting Person contributed 610,035 common shares (including 14,035 restricted shares which vested immediately prior to the effective time of the merger) to Parent in exchange for an equivalent amount of shares of common stock ("Parent Common Shares") of Parent, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP.
Signature
/s/ John F. Duggan, Attorney-in-Fact|2026-07-01